A transformative solution for CKM diseases

Centaurus is focused on developing safe and highly effective therapies that restore ceramide balance to treat disease. The Centaurus team includes the world’s foremost recognized experts in the field of ceramide research and industry experts with deep experience in CKM diseases, cardiometabolic biology, lipid metabolism, drug discovery and clinical development. Our advisors include leaders in nephrology, cardiology and metabolic disease research.

Our mission:

To develop transformative therapies that meaningfully improve outcomes for patients with CKM diseases and rare ceramide-driven disorders.

Centaurus is led by scientists, clinicians, and industry experts with deep experience in cardiometabolic biology, lipid metabolism, drug discovery, and clinical development. Our advisors include leaders in nephrology, cardiology, and metabolic disease research.

The team

Jeremy T. Blitzer, MD, PhD

Cofounder, Director, & CEO/CSO

Hubert Chen, MD

Medical & Regulatory Advisor

Donna Romero, PhD

Medicinal Chemistry

Scott Summers, PhD

Scientific Co-founder